Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Frontiers in Pharmacology|December 5, 2018
Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)Wing Lam, Yongshen Ren, Fulan Guan, et al.Science Translational Medicine|August 20, 2010
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicityWing Lam, Scott Bussom, Fulan Guan, et al.International Journal of Molecular Sciences|September 27, 2025
Dual Therapeutic Impact of AXL Inhibitor AB-329: Chemotherapy Sensitization and Immune Microenvironment Reprogramming in TNBCDileep Reddy Rampa, Jon A Fuson, Huey Liu, et al.Scientific Reports|August 2, 2022
Modeling geographical invasions of Solenopsis invicta influenced by land-use patternsChia-Hsien Lin, Yi-Huei Liu, Rong-Nan Huang, et al.Biomedicines|October 23, 2021
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer CellsBora Lim, Christine B Peterson, Alexander Davis, et al.Biomedicines|March 29, 2023
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell LinesXuemei Xie, Jangsoon Lee, Jon A Fuson, et al.Journal of Chromatography. A|July 10, 2025
Interpreting metabolic profiling of YIV906 in vivo: A Synergistic strategy combining LC-HRMS-based molecular networking and metabolomics thought integrationKailin Li, Aiping Tian, Liangyin Shu, et al.Proceedings of the National Academy of Sciences of the United States of America|January 9, 2025
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, et al.Molecular Cancer Therapeutics|December 16, 2020
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway-Dependent ApoptosisXuemei Xie, Jangsoon Lee, Huey Liu, et al.The Oncologist|November 3, 2020
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular CarcinomaChun A Changou, Her-Shyong Shiah, Li-Tzong Chen, et al.Pageof 4